British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic NA Kennedy, GR Jones, CA Lamb, R Appleby, I Arnott, RM Beattie, ... Gut 69 (6), 984-990, 2020 | 289 | 2020 |
The role of bile acids in functional GI disorders RN Appleby, JRF Walters Neurogastroenterology & Motility 26 (8), 1057-1069, 2014 | 89 | 2014 |
Integrin-mediated mechanotransduction in IL-1β stimulated chondrocytes TT Chowdhury, RN Appleby, DM Salter, DA Bader, DA Lee Biomechanics and modeling in mechanobiology 5, 192-201, 2006 | 72 | 2006 |
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab S Lin, NA Kennedy, A Saifuddin, DM Sandoval, CJ Reynolds, RC Seoane, ... Nature communications 13 (1), 1379, 2022 | 71 | 2022 |
Characterizing factors associated with differences in FGF19 blood levels and synthesis in patients with primary bile acid diarrhea IM Johnston, JD Nolan, SS Pattni, RN Appleby, JH Zhang, SL Kennie, ... Official journal of the American College of Gastroenterology| ACG 111 (3 …, 2016 | 59 | 2016 |
Non-alcoholic fatty liver disease is associated with dysregulated bile acid synthesis and diarrhea: A prospective observational study RN Appleby, I Moghul, S Khan, M Yee, P Manousou, TD Neal, ... PLoS One 14 (1), e0211348, 2019 | 42 | 2019 |
A positive SeHCAT test results in fewer subsequent investigations in patients with chronic diarrhoea JM Turner, SS Pattni, RN Appleby, JRF Walters Frontline Gastroenterology 8 (4), 279-283, 2017 | 32 | 2017 |
Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study S Sebastian, GJ Walker, NA Kennedy, TE Conley, KV Patel, ... The Lancet Gastroenterology & Hepatology 6 (4), 271-281, 2021 | 29 | 2021 |
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA. 1 and BA. 4/5 variants in patients with inflammatory bowel disease treated with infliximab and … Z Liu, K Le, X Zhou, JL Alexander, S Lin, C Bewshea, N Chanchlani, ... The Lancet Gastroenterology & Hepatology 8 (2), 145-156, 2023 | 24 | 2023 |
Novel associations of bile acid diarrhoea with fatty liver disease and gallstones: a cohort retrospective analysis RN Appleby, JD Nolan, IM Johnston, SS Pattni, J Fox, JRF Walters BMJ open gastroenterology 4 (1), e000178, 2017 | 17 | 2017 |
A variant of FGF19 for treatment of disorders of cholestasis and bile acid metabolism JRF Walters, RN Appleby Annals of Translational Medicine 3 (Suppl 1), 2015 | 13 | 2015 |
Effects of conventional and a novel colonic-release bile acid sequestrant, A3384, on fibroblast growth factor 19 and bile acid metabolism in healthy volunteers and patients … RN Appleby, A Bajor, PG Gillberg, H Graffner, M Simrén, KA Ung, ... United European Gastroenterology Journal 5 (3), 380-388, 2017 | 10 | 2017 |
A young woman with abdominal distension R Appleby, H Saroya, A Postgate, Z Meer Case Reports 2014, bcr2014203726, 2014 | 7 | 2014 |
Can we improve the negative predictive value of faecal calprotectin for the diagnosis of IBS in primary care? R Zayyat, RN Appleby, RPH Logan Gut 60 (Suppl 1), A49-A50, 2011 | 5 | 2011 |
Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID‐19 pandemic: the PREPARE‐IBD multicentre cohort study A Saifuddin, AJ Kent, SJ Mehta, LC Hicks, HA Gonzalez, JP Segal, ... Alimentary Pharmacology & Therapeutics 56 (10), 1460-1474, 2022 | 4 | 2022 |
Common genetic variants in the bile acid synthesis enzyme CYP7A1 are associated with severe primary bile acid diarrhea S Balesaria, SS Pattni, IM Johnston, JD Nolan, RN Appleby, JRF Walters Gastroenterology 163 (2), 517-519. e2, 2022 | 3 | 2022 |
Colesevelam Effectson Faecal Bile Acids in IBS-Diarrhoea JRF Walters, RN Appleby | 3 | 2015 |
PTH-022 Hemospray in a large tertiary nhs trust: a descriptive analysis of the first three years of use R Appleby, J Hoare Gut 66, A216, 2017 | 2 | 2017 |
PTU-106 improved survival and independance from parental nutrition for patients with intestinal dysmotility R Appleby, C Yu, J Nightingale Gut 65 (Suppl 1), A107-A107, 2016 | 2 | 2016 |
Cafestol but Not Resveratrol is a Partial Agonist of Farnesoidx Receptor and Stimulates FGF19 in Human Ileal Explants S Jameie-Oskooei, R Appleby, J Geers, J Walters Journal of Hepatology 2 (64), S684, 2016 | 2 | 2016 |